Neutrophil mobilization, the release of neutrophils from the bone marrow reserve into circulating blood, is important to increase peripheral neutrophil amounts during bacterial infections. Granulocyte colony-stimulating factor (G-CSF) and chemokines, such as MIP-2 (CXCL2), can induce neutrophil mobilization, but the mechanism(s) they employ remain unclear. The transcription factor STAT3 is the principal intracellular signaling molecule activated upon G-CSF-ligation of its receptor. Using a murine model with conditional STAT3 deletion in bone marrow, we demonstrated previously that STAT3 regulates acute G-CSF-responsive neutrophil mobilization and MIP-2-dependent neutrophil chemotaxis. In this study, we show that STAT3 is also necessary for MIP-2-elicited neutrophil mobilization. STAT3 appears to function by regulating the amplitude of Raf/MEK/Erk activation, a signaling pathway that is important for MIP-2-mediated chemotaxis. In addition, we demonstrate that G-CSF stimulates the expression of the MIP-2 receptor via STAT3-dependent transcriptional activation of Il8rb. G-CSF treatment also induces changes in bone marrow chemokine expression levels in a STAT3-dependent manner, which may further affect neutrophil retention and release.
Introduction
Neutrophils are cells of the innate immune system that have critical roles in managing bacterial and fungal infections, as their major effector functions are phagocytosis and release of anti-bacterial peptides, proteases, and reactive oxygen species. 1 Patients with congenital or acquired neutropenias have increased susceptibility to life-threatening infections. 2 These patients are often treated with recombinant granulocyte colonystimulating factor (G-CSF), which promotes myeloid progenitor cell proliferation and neutrophil differentiation, as well as neutrophil mobilization from the bone marrow reserve into circulating blood. G-CSF is commonly used in conjunction with chemotherapy, which can induce neutropenia. However, some patients do not respond well to G-CSF for reasons that are unclear. In fact, the mechanisms of G-CSF action are not well understood, thus prompting further investigation into its molecular function.
G-CSF binds the homodimeric G-CSF receptor (G-CSFR)
, which activates the associated Jak1 and Jak2 protein tyrosine kinases, and in turn stimulates the transcription factors STAT1, STAT3 and STAT5. 3 STATs form dimers and accumulate in the nucleus, where they activate transcription of cytokine-responsive genes. Experiments in vitro demonstrated that G-CSF weakly activates STAT1 and STAT5, but strongly activates STAT3. 4 Deletion of STAT3 in the bone marrow results in neutrophilia, indicating that STAT3 restrains granulopoiesis under steady state conditions. [5] [6] [7] [8] is required to activate SOCS3, which is important in terminating signals from the G-CSFR. 9 Therefore, these data collectively suggest that STAT3-SOCS3 signaling is required to suppress steady state granulopoiesis.
Additional work, however, suggested a more complex role for STAT3 in neutrophil regulation. The STAT3 recruitment site in the G-CSFR was found to be critical for controlling G-CSF-responsive neutrophil production and mobilization. 10 Moreover, we showed that STAT3 regulates G-CSF-dependent accumulation of immature bone marrow granulocytes and acute G-CSF-induced neutrophil mobilization, indicating important roles in neutrophil production and function under demand conditions. 7 STAT3-deficient neutrophils have a cell autonomous defect in migration
For personal use only. on . by guest www.bloodjournal.org From 4 toward ligands for CXCR2, 7 the major chemokine receptor expressed on murine neutrophils. 11 Here, we investigated the mechanisms by which STAT3 regulates neutrophil mobilization in response to G-CSF or the CXCR2 ligand, MIP-2. Our studies revealed that STAT3 controls MIP-2-responsive neutrophil mobilization from the bone marrow.
STAT3 regulates the amplitude of MIP-2-induced Raf/MEK/ERK signaling, which is necessary for CXCR2-mediated neutrophil chemotaxis. Moreover, G-CSF directly induces CXCR2 expression on immature neutrophils in a STAT3-dependent manner and enhances their responsiveness to MIP-2. G-CSF treatment stimulates MIP-2 and represses SDF-1 expression in the bone marrow microenvironment via a STAT3-dependent pathway. Therefore, we demonstrate that STAT3 regulates CXCR2 expression and function, as well as the production of chemokines in the bone marrow microenvironment, thus controlling several stages of the neutrophil mobilization response.
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Materials and methods
Bone marrow STAT3-deficient mice, cell isolation
STAT3-deficient (Tg(Tek-cre)12Flv, Stat3 f/Δ ) and control mice were bred as described, 7 maintained in a specific pathogen free (SPF) facility and used with the approval of the Institutional Animal Care and Use Committee (IACUC) guidelines at UT M. D.
Anderson Cancer Center (UT MDACC).
Blood, bone marrow and spleen cells were isolated as described previously. 7 Complete blood count analysis and absolute neutrophil levels were determined as described. 
G-CSF and MIP-2 administration in vivo
Following dilution in sterile PBS containing endotoxin-free BSA (BSA/PBS), recombinant human G-CSF (Amgen) was administered by subcutaneous injection (250μg/kg, 24 h prior) and murine MIP-2 (Peprotech) by intraperitoneal injection (50μg/kg, 30 min prior). Control mice received equivalent volumes of BSA/PBS or remained untreated.
Ex vivo MIP-2 stimulation, immunoblot analysis
Bone marrow neutrophils were treated with MIP-2 (100ng/mL) ± pre-treatment with U0126 inhibitor (Promega). Whole cell lysates were analyzed by immunoblotting with antibodies against phospho-c-Raf (Ser338), phospho-MEK1/2 (Ser217/Ser221), phospho-ERK1/2 (Thr202/Tyr204), total c-Raf, total MEK1/2 (Cell Signaling), or total ERK2 (SantaCruz). Densitometric analyses were performed using NIH ImageJ software version 1.42q (http://rsbweb.nih.gov/ij/).
Chemotaxis assays
Bone marrow neutrophils were resuspended in DMEM/BSA and plated in 3μm
Transwells® (Fisher Scientific) ± SDF-1α (250ng/mL, Peprotech) or MIP-2, as described. 7 Cells were pretreated in U0126 for 30 min as indicated. 
RNA isolation, real-time PCR
Total RNA was isolated using Tri-Reagent® (Molecular Research Center), and reverse transcribed using iScript cDNA Synthesis kit (Bio-Rad). Real-time PCR was performed using iQ SYBR Green Supermix, detected on the iQ5 Real-Time PCR Detection System and analyzed using iQ5 Optical System Software (Bio-Rad). Calculations were performed as previously described.
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Primers used were Il8rb Forward 5'-
32D cell culture, retroviral transduction 32D cells expressing human G-CSFR (32D.G-CSFR) were generated by retroviral transduction with transfer vector pMX-G-CSFR-IRES-GFP. GFP-G-CSFR + cells were enriched by FACS. Cells were maintained in RPMI/10% FCS/10% WEHI-conditioned media (source of IL-3).
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Identification of the Il8rb promoter, reporter assays
The putative proximal promoter for Il8rb (ENSMUSG00000026180) was identified using Ensembl, and the putative STATx site was found using TFSEARCH (http://www.cbrc.jp/research/db/TFSEARCH.html). The Il8rb promoter was amplified using AccuPrime™ Pfx DNA Polymerase (Invitrogen) and the following primers:
Forward 5'-GGAGGTACCGCACAGCAAGCTGAGAGG-3' and Reverse 5'-GGAAGATCTGACCTGGGCTACCGATGGGGA-3' and cloned into the pGL3-Basic plasmid (Promega). The mutation in the STATx site was induced by PCR-based mutagenesis. Sequences were confirmed by the UT MDACC DNA Core Analysis Facility.
32D.G-CSFR cells were electroporated using Cell Line Nucleofector® Kit V (Lonza) and
The Nucleofector® Device (Lonza), and treated with 25ng/ml rhG-CSF (Amgen).
Luciferase activity was measured using the Dual-Luciferase Reporter Assay System (Promega) and a Sirius luminometer (Berthold Detection Systems).
Electrophoretic mobility shift assays (EMSAs), chromatin immunoprecipitations (ChIPs)
EMSAs were performed as described. 17 EMSA oligonucleotide sequences are as follows: 
Analysis of SDF-1 binding
Recombinant SDF-1α containing a human Fc tag was a generous gift from Dr. Qing Ma.
SDF-1α binding was determined for the Gr-1 + population, using bone marrow cells that Figure 1B ). Bone marrow neutrophil numbers were reduced by approximately 50% in wild type mice upon MIP-2 treatment, while STAT3-deficient animals failed to show a significant decline ( Figure   1B ). STAT3-deficient and wild type neutrophils expressed equivalent levels of CXCR2
and showed a similar extent of ligand-mediated receptor downregulation ( Figure 1C ).
These results demonstrate that MIP-2-stimulated neutrophil migration from the bone marrow to the blood is impaired in STAT3-deficient mice without effects on basal CXCR2 expression, suggesting STAT3 may regulate other aspects of the MIP-2 mobilization response, such as CXCR2 signaling. Figure 1D ).
CXCR2-dependent ERK1
Similarly, activation of MEK1/2 and Raf was suppressed in STAT3-deficient neutrophils compared to wild type cells ( Figure 1D ). By contrast, we were unable to detect differences in p38 or Akt phosphorylation levels between wild type and STAT3-deficient neutrophils, and neutrophils from both genotypes elicited similar amounts of intracellular 
G-CSF treatment in vivo stimulates STAT3-dependent induction of CXCR2 expression in neutrophils.
Like MIP-2-dependent neutrophil mobilization, G-CSF-responsive neutrophil mobilization requires STAT3, 7 but the mechanisms involved are not clearly defined. G-CSF itself is not directly chemotactic in murine models; 19 however, G-CSF is reported to regulate the expression of CXCR2. 20 We therefore examined whether STAT3 stimulated CXCR2 expression during neutrophil development or in response to G-CSF treatment in vivo. The total Gr-1 + bone marrow neutrophil population can be subdivided into immature Gr-1 lo granulocytes and mature Gr-1 hi neutrophils, 7, 21 thus permitting analysis of CXCR2 expression at discrete developmental stages by flow cytometry. We found that the majority of mature Gr-1 hi bone marrow neutrophils expressed cell surface CXCR2: no significant differences were detected between wild type and STAT3-deficient cells in steady state conditions ( Figure 2A , upper right panel; Figure 2B ).
Immature Gr-1 lo granulocytes showed heterogeneous expression of cell surface CXCR2
in the basal state and expressed reduced CXCR2 levels relative to mature Gr-1 hi neutrophils, as judged by differences in mean fluorescence intensity (MFI) (i.e., MFI=1007 ± 126 for wild type Gr-1 lo vs. MFI=2877 ± 295 for wild type Gr-1 hi neutrophils, P<0.001) ( Figure 2A , upper panels; Figure 2B ; data not shown).
Additionally, wild type and STAT3-deficient immature Gr-1 lo granulocytes expressed similar levels of CXCR2 on the cell surface under steady state conditions ( Figure 2A , upper left panel; Figure 2B ). In agreement, we found that basal mRNA levels of Il8rb, the gene encoding CXCR2, were comparable in wild type and STAT3-deficient immature Gr-1 lo granulocytes ( Figure 2C ). Il8rb mRNA levels were significantly elevated in mature Gr-1 hi neutrophils, relative to immature Gr-1 lo granulocytes, and again no obvious differences were found between wild type and STAT3-deficient cells in the basal state ( Figure 2C ). These data indicate that Il8rb mRNA and cell surface CXCR2 expression are induced during neutrophil differentiation in vivo, yet the pathways that control developmental expression are independent of functional STAT3.
Examination of CXCR2 in G-CSF-treated mice showed that cell surface CXCR2 expression was significantly induced in wild type immature Gr-1 lo granulocytes, versus cells from untreated animals ( Figure 2A , left panels; Figure 2B ). Moreover, G-CSF upregulated cell surface CXCR2 expression on wild type mature Gr-1 hi neutrophils, 
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This prompted us to test the expression of chemokines in bone marrow samples from wild type or STAT3-deficient mice in response to G-CSF. We found G-CSF-dependent induction of Cxcl2 mRNA, which encodes MIP-2 (CXCL2), the murine homologue of human IL-8, in bone marrow of wild type but not STAT3-deficient mice ( Figure 4A ). We observed a similar trend for Cxcl1, which encodes KC (CXCL1), a distinct CXCR2 chemokine ( Figure 4B ). Furthermore, G-CSF administration upregulated Il8rb in wild type but not STAT3-deficient bone marrow ( Figure 4C ), similar to its induction in neutrophils ( Figure 2C ). Collectively, these results suggest that G-CSF stimulates mRNA expression of the neutrophil chemotactic molecules MIP-2 and KC within the bone marrow microenvironment, a response that is abrogated by hematopoietic STAT3 deletion. 
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In contrast to the function of MIP-2 and KC, SDF-1 (CXCL12) mediates the retention of hematopoietic stem and granulocytic progenitor cells in the bone marrow via interaction with its receptor CXCR4. 
STAT3-deficient mice fail to mobilize neutrophils in response to L. monocytogenes infection and exhibit prolonged infection.
To determine whether the role for STAT3 in G-CSF-and MIP-2-responsive neutrophil mobilization reflected STAT3 function during bacterial infection, we assessed neutrophil mobilization in wild type and STAT3-deficient mice following infection with L. 
monocytogenes, a bacterial pathogen that is restrained by the actions of G-CSF in
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Discussion
Here, we demonstrate that STAT3 controls several aspects of the bone marrow response to the mobilizing agents MIP-2 or G-CSF. These include ligand-inducible neutrophil mobilization, CXCR2 signal transduction, G-CSF-responsive CXCR2 expression in immature granulocytes, and bone marrow chemokine mRNA expression following G-CSF administration (Figure 6 ). Circulating neutrophils have a relatively short half-life (t 1/2 ~6-8 h). Thus, continued replenishment from the bone marrow neutrophil reserve is necessary to sustain blood neutrophil levels, and these can be further enhanced during infection 30 or clinical use of G-CSF. While G-CSF therapy is common, little is understood regarding the mechanisms by which it elicits neutrophil mobilization.
Because G-CSF is itself not chemotactic, 19 we and others have hypothesized that CXCR2
and its ligands, e.g., MIP-2 and KC, participate in G-CSF-responsive neutrophil mobilization. 7, 18, 19 This concept is supported by the observation that G-CSF fails to induce circulating neutrophil amounts in CXCR2-knockout mice. 18 Our data demonstrate a role for STAT3 in neutrophil responses to G-CSF and MIP-2, further suggesting a functional relationship between these mobilization pathways.
The inability of STAT3-deficient mice to enhance peripheral blood neutrophil numbers upon MIP-2 treatment suggested a defective mobilization response. However, STAT3-deficient mice are neutrophilic at steady state, which complicates analysis of neutrophil responses. Previously, we showed that sustained G-CSF treatment induces peripheral blood neutrophils approximately 10-fold beyond the steady state amount in both wild type and STAT3-deficient mice, 7 ruling out the idea that circulating amounts are saturated in STAT3-deficient animals under basal conditions. Moreover, we found that bone marrow neutrophils were significantly decreased in wild type mice by MIP-2
treatment, yet unaffected in STAT3-deficient animals. Since the reduction in wild type bone marrow neutrophil numbers could not be accounted for by accumulation in other hematopoietic organs (peripheral blood or spleen), the results suggest MIP-2 elicits neutrophil mobilization as well as margination to non-hematopoietic tissues. STAT3-deficient mice were non-responsive to MIP-2, indicating deficient neutrophil 36, 37 Little is known about the control of chemokine receptor expression, however deregulated CXCR2-mediated neutrophil migration has been linked to inflammatory Previous studies with human neutrophils produced conflicting results as to the chemokinetic or chemotactic properties of G-CSF, 41 while G-CSF did not show chemokinetic or chemotactic activity upon murine neutrophils. 19 Trans-acting factors are, however, known to be important in the neutrophil mobilization response to G-CSF, 42 suggesting that regulated chemokine expression may participate in neutrophil release under G-CSF-driven demand conditions. We found that G-CSF induces MIP-2 and KC expression in the bone marrow of wild type mice, consistent with induction of serum IL-8 in humans receiving G-CSF therapy. 22 G-CSF-responsive induction of MIP-2 and KC was not observed in STAT3-deficient bone marrow, indicating a role for STAT3 in regulation of these chemokines. Because the G-CSFR is expressed mainly on myeloid cells, 43 and myeloid cells including neutrophils produce MIP-2, we speculate that the myeloid subset is a primary G-CSF target population that is responsible for MIP-2 production. Moreover, CXCR2 knockout mice were reported to have impaired neutrophil mobilization in response to G-CSF, underscoring the importance of CXCR2 in inducible neutrophil release. 18 Thus, collectively, data from our lab and others suggests that G-CSF-dependent neutrophil mobilization may utilize several distinct mechanisms related to CXCR2 function, including regulated synthesis of MIP-2 and KC in bone
For personal use only. on November 16, 2017. by guest www.bloodjournal.org From marrow as well as inducible CXCR2 receptor expression and control of CXCR2 signal transduction. 18, 19 SDF-1 is constitutively expressed in the bone marrow, contributing to the retention of cells that express CXCR4. 23 Inhibiting the SDF-1/CXCR4 interaction is sufficient to enable neutrophil release, as shown by use of the CXCR4 antagonist AMD3100. 44 We found that G-CSF treatment decreases bone marrow SDF-1 expression in wild type mice, in agreement with previous reports. supervised the project, analyzed data and wrote the paper.
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